View of THE ROLE OF SODIUM–GLUCOSE COTRANSPORTER-2 (SGLT2) INHIBITORS IN REDUCING THE RISK OF CARDIOVASCULAR EVENTS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS : A SYSTEMATIC REVIEW OF RANDOMIZED CONTROLLED TRIALS AND PRIMARY STUDIES

Return to Article Details THE ROLE OF SODIUM–GLUCOSE COTRANSPORTER-2 (SGLT2) INHIBITORS IN REDUCING THE RISK OF CARDIOVASCULAR EVENTS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS : A SYSTEMATIC REVIEW OF RANDOMIZED CONTROLLED TRIALS AND PRIMARY STUDIES Download Download PDF